Since MPO−463G>A polymorphism may be associated with weaker transcriptional activity and decreases the enzyme levels, carcinogens contained in cigarette smoking will not be metabolically activated by MPO enzyme, therefore this polymorphism has been suggested to have a protective effect against the development of cancers related to smoking such as lung cancer [42], [43]. The gene discussed is MPO; the disease is lung cancer.